Change of Scaling-Induced Proinflammatory Cytokine on the Clinical Efficacy of Periodontitis Treatment

Table 1

Demographic characteristics and conventional periodontitis risk factors of study subjects by treatment outcome strata.

	NP group ( = 12)	ET group ( = 10)	value
	Median (Q1–Q3)
Age, years	61.5; (46–71)	56.0; (44–60)	0.37^a
Distribution of subjects	(%)	(%)
Gender			0.63^b
Male	5 (41.67)	4 (40.00)
Female	7 (58.33)	6 (60.00)
Education			0.41^b
High school	4 (33.33)	2 (20.00)
University or above	8 (66.67)	8 (80.00)
Smoking			0.22^b
Nonsmokers	10 (83.33)	6 (60.00)
Smokers	2 (16.67)	4 (40.00)
Alcohol consumption			0.71^b
Never or occasional	11 (91.67)	9 (90.00)
Regular	1 (8.33)	1 (10.00)
Betel nut chewing			0.19^b
Nonchewer	12 (100.00)	8 (80.00)
Chewer	0 (0.00)	2 (20.00)
Dental visiting pattern			0.96^b
Regular visits (<1 year)	8 (66.37)	9 (90.00)
Irregular visits (≥1 year)	4 (33.33)	1 (10.00)
Tooth cleaning frequency			0.97^b
<2 times/day	1 (8.33)	3 (30.00)
≥2 times/day	11 (91.67)	7 (70.00)

Mann-Whitney test.
^bFisher’s exact test.
NP group: nonprogress treatment group.
ET group: effective treatment group.